Unum Group (UNM) Expected to Announce Quarterly Earnings on Tuesday

Unum Group (NYSE:UNM) is expected to be posting its quarterly earnings results after the market closes on Tuesday, February 4th. Analysts expect Unum Group to post earnings of $2.14 per share and revenue of $3.29 billion for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Unum Group Stock Down 1.0 %

Shares of NYSE:UNM opened at $76.25 on Monday. Unum Group has a 12-month low of $46.39 and a 12-month high of $77.69. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. The stock’s 50-day moving average price is $74.23 and its 200-day moving average price is $64.68. The stock has a market capitalization of $13.92 billion, a P/E ratio of 8.25, a price-to-earnings-growth ratio of 1.09 and a beta of 0.81.

Unum Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be given a $0.42 dividend. The ex-dividend date is Friday, January 24th. This represents a $1.68 annualized dividend and a yield of 2.20%. Unum Group’s payout ratio is currently 18.18%.

Insider Activity at Unum Group

In other news, EVP Lisa G. Iglesias sold 5,000 shares of the company’s stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $72.61, for a total transaction of $363,050.00. Following the transaction, the executive vice president now directly owns 35,840 shares of the company’s stock, valued at $2,602,342.40. This represents a 12.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Christopher W. Pyne sold 3,250 shares of Unum Group stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $70.02, for a total value of $227,565.00. Following the completion of the sale, the executive vice president now owns 50,762 shares of the company’s stock, valued at $3,554,355.24. The trade was a 6.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 102,914 shares of company stock valued at $7,677,945 in the last 90 days. Corporate insiders own 0.93% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on UNM. Wells Fargo & Company lifted their target price on shares of Unum Group from $74.00 to $81.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 14th. Jefferies Financial Group upped their price objective on shares of Unum Group from $91.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, December 10th. Morgan Stanley raised their target price on Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 30th. BMO Capital Markets started coverage on Unum Group in a research report on Thursday, January 23rd. They set an “outperform” rating and a $91.00 price target for the company. Finally, Piper Sandler lifted their price objective on Unum Group from $74.00 to $82.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 18th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.00.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.